BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 15644430)

  • 1. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis.
    Fiorucci S; Clerici C; Antonelli E; Orlandi S; Goodwin B; Sadeghpour BM; Sabatino G; Russo G; Castellani D; Willson TM; Pruzanski M; Pellicciari R; Morelli A
    J Pharmacol Exp Ther; 2005 May; 313(2):604-12. PubMed ID: 15644430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of FXR in regulating bile acid homeostasis and relevance for human diseases.
    Rizzo G; Renga B; Mencarelli A; Pellicciari R; Fiorucci S
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Sep; 5(3):289-303. PubMed ID: 16178789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis.
    Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Morelli A; Pruzanski M; Pellicciari R
    J Pharmacol Exp Ther; 2005 Oct; 315(1):58-68. PubMed ID: 15980055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
    Zhang F; Xi L; Duan Y; Qin H; Wei M; Wu Y; Li B; Zhou Y; Wu X
    Eur J Pharm Sci; 2018 Oct; 123():404-415. PubMed ID: 30077711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity.
    Pellicciari R; Fiorucci S; Camaioni E; Clerici C; Costantino G; Maloney PR; Morelli A; Parks DJ; Willson TM
    J Med Chem; 2002 Aug; 45(17):3569-72. PubMed ID: 12166927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
    Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
    Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
    Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
    Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis.
    Fiorucci S; Antonelli E; Rizzo G; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pellicciari R; Morelli A
    Gastroenterology; 2004 Nov; 127(5):1497-512. PubMed ID: 15521018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes.
    Rizzo G; Renga B; Antonelli E; Passeri D; Pellicciari R; Fiorucci S
    Mol Pharmacol; 2005 Aug; 68(2):551-8. PubMed ID: 15911693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis.
    Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pruzanski M; Morelli A; Pellicciari R
    J Pharmacol Exp Ther; 2005 Aug; 314(2):584-95. PubMed ID: 15860571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamine attenuates obstructive cholestasis in rats via farnesoid X receptor-mediated regulation of Bsep and Mrp2.
    Liu B; Li Y; Ji H; Lu H; Li H; Shi Y
    Can J Physiol Pharmacol; 2017 Feb; 95(2):215-223. PubMed ID: 28051334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
    Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice.
    Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Huo X; Liu Z; Yao J; Liu K
    Pharm Res; 2015 Nov; 32(11):3688-98. PubMed ID: 26040663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dolomiaea souliei ethyl acetate extract protected against α-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid x receptor-mediated bile acid metabolism.
    Meng F; Zong W; Wei X; Tao Y; Wang G; Liao Z; Chen M
    Phytomedicine; 2021 Jul; 87():153588. PubMed ID: 34091148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
    Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
    Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.
    Deng R; Yang D; Yang J; Yan B
    J Pharmacol Exp Ther; 2006 Apr; 317(1):317-25. PubMed ID: 16371446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yangonin protects against estrogen-induced cholestasis in a farnesoid X receptor-dependent manner.
    Dong R; Wang J; Gao X; Wang C; Liu K; Wu J; Liu Z; Sun H; Ma X; Meng Q
    Eur J Pharmacol; 2019 Aug; 857():172461. PubMed ID: 31220436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoprotection of auraptene from the peels of citrus fruits against 17α-ethinylestradiol-induced cholestasis in mice by activating farnesoid X receptor.
    Wang J; Fu T; Dong R; Wang C; Liu K; Sun H; Huo X; Ma X; Yang X; Meng Q
    Food Funct; 2019 Jul; 10(7):3839-3850. PubMed ID: 31210195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.